The last outbreak of cholera in Britain was in 1866; in the United States there has not been an outbreak since 1911. And yet today people are sick with this ancient disease in 32 countries, with more than 6,800 deaths reported so far this year already exceeding all of last year's toll of 6,000 deaths, which was itself a 50% increase on 2023.
Antibiotics have turned once deadly infections into minor inconveniences. They make lifesaving interventions, from surgery to chemotherapy, safer. But every time this powerful tool gets used, there's a risk antibiotic resistance. Out of the billions of bacteria causing an infection in an individual, some small fraction may be naturally resistant to a given drug. Taking an antibiotic can clear the field for those resistant bacteria to spread.
Dr. Solomon Zewdu is based in South Africa and he says the thing that struck him most this General Assembly is that global health leaders are "talking in silos." "We're not hearing each other," he says. Some are having conversations about how dependent countries are on aid, while others are lamenting the cuts. "But now, what's the next step? Let's move on. There's urgency. Time kills people," he says. He's afraid "everybody's going to scatter, and then we might wait for the next summit to happen and, in between, people dying, people's health is being compromised."
The extremely limited availability of mpox vaccines in DRC has already drastically reduced the reach of the national strategic plan for vaccination against mpox. This means that without improved access to vaccines, thousands of people may be left unprotected.
World leaders face immense challenges in securing funds for development. Aid cuts have disrupted health and humanitarian work while economic instability drains government resources.
I was born in Thomasville, Alabama, and raised in Florida. I'm the first male of seven siblings, and our parents, especially my father who was a preacher, taught us to live with purpose. Four of us were high school valedictorians. I studied chemistry and biology at Oakwood University and then entered Loma Linda Medical School, finishing in three years. I knew early on I wanted to help others.
Although this is a first step and national health systems still need to develop policies to implement the resolution, experts agree that the measure opens a new path for skin conditions to be seen not merely as an aesthetic issue but as a global public health priority.